Clinical Trial Update: A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability, safety and tolerability of single- and multiple-doses of Elinzanetant in healthy female participants; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms

Drugs mentioned

• Elinzanetant (elinzanetant)

Snippet

Sponsor: Bayer | Conditions: Vasomotor Symptoms | Phase 1 | Status: COMPLETED